Pharmaceuticals,
Год журнала:
2024,
Номер
17(12), С. 1658 - 1658
Опубликована: Дек. 9, 2024
Food
supplements
are
used
for
a
variety
of
purposes,
one
which
is
weight
reduction.
As
excess
long-term
condition,
some
expected
to
be
long
periods
time.
The
use
these
dietary
makes
it
highly
likely
that
they
will
combined
with
medications,
increasing
the
risk
food
supplement–drug
interactions,
not
always
known
or
disclosed,
and
can
lead
serious
health
problems,
as
has
been
observed.
This
article
discusses
compounds
reduction
(green
tea
extract,
Garcinia
cambogia,
chitosan,
quercetin
resveratrol)
interactions
may
cause
drugs
such
as:
dextromethorphan,
buspirone,
diclofenac,
irinotecan,
5-fluorouracil,
cytochrome
P450
inducers
inhibitors,
statins,
orlistat,
warfarina,
acenocoumarol,
fluoxetine,
valproate,
quetiapine,
carbamazepine.
information
useful
healthcare
professionals
detect
intervene
on
ensure
optimization
therapy
patient
safety.
Activation
of
mitochondrial
function
and
heat
production
in
adipose
tissue
by
the
modification
dietary
fat
is
a
promising
strategy
against
obesity.
However,
as
an
important
source
lipids
for
ketogenic
daily
diets,
fats
extracted
from
different
sites
was
largely
unknown.
In
this
study,
we
illustrated
tissues
with
“beigeing”
properties
diet
identified
lipid
profiles
that
facilitate
energy
expenditure.
We
found
anti-obesity
effect
diets
potentiated
using
[porcine
subcutaneous
(SAT)]
major
energy-providing
ingredient.
Through
lipidomic
analyses,
phosphatidylserine
(PS)
functional
activating
thermogenesis
tissue.
Moreover,
vivo
studies
showed
PS
induces
alleviates
diet-induced
obesity
mice.
vitro
promotes
UCP1
expression
lipolysis
adipocytes.
Mechanistically,
promoted
adipocytes
via
ADCY3-cAMP-PKA-PGC1α
pathway.
addition,
PS-PGC1a
binding
may
affect
stability
PGC1α
protein,
which
further
augments
PS-induced
thermogenesis.
These
results
demonstrated
efficacy
SAT
diminishing
accumulation
underlying
molecular
mechanism
enhancing
function.
Thus,
our
findings
suggest
fat,
provides
more
beneficial
contribute
to
improvement
function,
including
PS,
become
novel,
nonpharmacological
therapy
increase
expenditure
counteract
its
related
diseases.
Frontiers in Pharmacology,
Год журнала:
2023,
Номер
14
Опубликована: Май 10, 2023
Introduction:
The
global
prevalence
of
obesity
is
rising
rapidly.
Conversion
white
adipose
tissue
(WAT)
into
beige
with
heat-consuming
characteristics,
i.e.,
WAT
browning,
effectively
inhibits
obesity.
Dai-Zong-Fang
(DZF),
a
traditional
Chinese
medicine
formula,
has
long
been
used
to
treat
metabolic
syndrome
and
This
study
aimed
explore
the
pharmacological
mechanism
DZF
against
Methods:
In
vivo
,
C57BL/6J
mice
were
fed
high-fat
diets
establish
diet-induced
obese
(DIO)
model.
(0.40
g/kg
0.20
g/kg)
metformin
(0.15
g/kg,
positive
control
drug)
as
intervention
drugs
for
six
weeks,
respectively.
effects
on
body
size,
blood
glucose
lipid
level,
structure
morphology
adipocytes
browning
inguinal
(iWAT)
in
DIO
observed.
vitro
mature
3T3-L1
Concentrations
(0.8
mg/mL
0.4
mg/mL)
selected
according
Cell
Counting
Kit-8
(CCK8).
After
2d
intervention,
droplet
was
observed
by
BODIPY493/503
staining,
mitochondria
number
mito-tracker
Green
staining.
H-89
dihydrochloride,
PKA
inhibitor,
observe
change
markers′
expression.
expression
levels
markers
UCP1
PGC-1α
key
molecules
pathway
detected
.
Results:
compared
vehicle
group,
0.40
significantly
reduced
from
weight,
abdomen
circumference,
Lee′s
index,
WAT/body
weight
(
p
<
0.01
or
0.001).
also
fasting
(FBG),
serum
triglycerides
(TG),
total
cholesterol
(TC),
low-density
lipoprotein
(LDL-C)
iWAT′s
after
intervention.
HE-staining,
droplets
became
smaller,
increased.
mitochondrial
remodeled
under
electron
microscope.
UCP1,
elevated
iWAT
RT-qPCR
0.05
vitro,
0.8
increased
PGC-1α,
PKA,
pCREB
0.01).
contrast,
reversed
adding
inhibitor
dihydrochloride.
Conclusion:
can
promote
activating
pathway,
thereby
promoting
WAT,
attenuating
obesity,
reducing
obesity-related
metabolism
abnormalities,
indicating
that
potential
be
an
anti-obesity
drug
benefit
patients.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Авг. 14, 2024
Introduction:
Obesity,
a
global
epidemic,
is
caused
by
an
imbalance
between
energy
intake
and
expenditure.
The
induction
of
white
adipose
browning
to
increase
heat
production
has
emerged
as
potential
effective
strategy
address
obesity.
Ling-gui-zhu-gan
(LGZG),
traditional
Chinese
medicine
formula,
been
proved
achieve
promising
results
combat
obesity
related
metabolic
diseases,
yet
the
mechanisms
remain
largely
unexplored.
This
study
aimed
elucidate
anti-obesity
properties
LGZG
investigating
its
effect
on
3T3-L1
adipocytes.
Methods:
LGZG-containing
serum
obtained
oral
administration
animals
was
added
adipocytes
simulate
in
vivo
conditions.
Results:
showed
that
49
compounds
were
identified
UHPLC-Q-Orbitrap
HRMS,
including
such
atractylenolides
polyporenic
acid
C,
etc.
alleviated
lipid
accumulation
decreased
both
intracellular
extracellular
triglyceride
contents
dose-dependent
manner.
reduction
accompanied
enhanced
mitochondrial
respiratory
function.
Mechanistically,
led
decrease
miR-27b
expression
mRNA
protein
levels
browning-related
markers,
UCP1,
PRDM16,
PGC-1α,
PPARγ,
CTBP1,
CTBP2.
Further
investigation
using
mimic
transfection
confirmed
miR-27b/PRDM16
pathway
might
be
mechanism
which
promotes
Discussion:
These
underscore
therapeutic
addressing
associated
disorders
through
promotion
browning.
Pharmaceuticals,
Год журнала:
2024,
Номер
17(12), С. 1658 - 1658
Опубликована: Дек. 9, 2024
Food
supplements
are
used
for
a
variety
of
purposes,
one
which
is
weight
reduction.
As
excess
long-term
condition,
some
expected
to
be
long
periods
time.
The
use
these
dietary
makes
it
highly
likely
that
they
will
combined
with
medications,
increasing
the
risk
food
supplement–drug
interactions,
not
always
known
or
disclosed,
and
can
lead
serious
health
problems,
as
has
been
observed.
This
article
discusses
compounds
reduction
(green
tea
extract,
Garcinia
cambogia,
chitosan,
quercetin
resveratrol)
interactions
may
cause
drugs
such
as:
dextromethorphan,
buspirone,
diclofenac,
irinotecan,
5-fluorouracil,
cytochrome
P450
inducers
inhibitors,
statins,
orlistat,
warfarina,
acenocoumarol,
fluoxetine,
valproate,
quetiapine,
carbamazepine.
information
useful
healthcare
professionals
detect
intervene
on
ensure
optimization
therapy
patient
safety.